In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials

The development of vaginal microbicides for the prevention of sexual transmission of HIV is becoming an increasingly important strategy in the battle against the AIDS epidemic. Several first generation microbicide candidates are entering Phase III efficacy trials, and several other candidates are in...

Ausführliche Beschreibung